Concepedia

Performance of PD-L1 immunohistochemistry (IHC) assays in unresectable locally advanced or metastatic triple-negative breast cancer (mTNBC): Post-hoc analysis of IMpassion130

H. S. Rugo, Sherene Loi, Sylvia Adams, Peter Schmid, C.H. Barrios, Hiroji Iwata, V. Diéras, EP Winer, Mark Kockx, Dieter Peeters,

Annals of Oncology · 2019 · 115 citations · 0 references

Open access

Concepts

MedicineOncologyBreast OncologyMedical OncologyMetastasisBreast Cancer OncologyImmuno-oncology BiomarkersImmunohistochemistryLocally Advanced Breast CancerMetastatic Breast CancerPd-l1 BlockadePost Hoc AnalysisPost Hoc Subgroup AnalysisProgrammed Death-ligand 1 BiomarkerTriple-negative Breast Cancer TherapyTriple-negative Metastatic Disease